Altered age‐linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT‐preAD study) with high brain amyloid load

INTRODUCTION: An effective therapy has not yet been developed for Alzheimer's disease (AD), in part because pathological changes occur years before clinical symptoms manifest. We recently showed that decreased plasma DYRK1A identifies individuals with mild cognitive impairment (MCI) or AD, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (N Y)
Autors principals: Delabar, Jean M., Ortner, Marion, Simon, Stephanie, Wijkhuisen, Anne, Feraudet‐Tarisse, Cecile, Pegon, Jonathan, Vidal, Emma, Hirschberg, Yael, Dubois, Bruno, Potier, Marie‐Claude
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331462/
https://ncbi.nlm.nih.gov/pubmed/32642550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars